432p * patterns and efficacy of bevacizumab use across treatment lines in glioblastoma
Conclusions: Our results show bevacizumab treatment may be more efficient after a recurrence than when used in the beginning of treatment and are in line with reported registration trials data.Disclosure: All authors have declared no conflicts of interest.
Source: Annals of Oncology - Category: Cancer & Oncology Authors: Azam, M. B., Rho, Y. S., Mamo, A., Sahebjam, S., Muanza, T., Guiot, M., Al-Shami, J., Sharma, R., Kavan, P. Tags: CNS tumours Source Type: research
More News: Avastin | Brain | Cancer & Oncology | Heart Attack | Hemorrhagic Stroke | Hospital Management | Hypertension | Neurology | Proteinuria | Pulmonary Thromboembolism | Stroke | Thrombocytopenia | Thrombosis | Toxicology